Loss of Pten promotes angiogenesis and enhanced vegfaa expression in zebrafish

DMM Disease Models and Mechanisms

Volumn 6, Issue 5, 2013, Pages 1159-1166

  Choorapoikayil, Suma ^a   Weijts, Bart ^b   Kers, Rianne ^a   De Bruin, Alain ^b   Den Hertog, Jeroen ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SUNITINIB;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG MECHANISM; EMBRYO; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PTEN GENE; TUMOR VASCULARIZATION; VEGFAA GENE; ZEBRA FISH;

ANIMALS; CHROMONES; DRUG THERAPY, COMBINATION; ENDOTHELIAL CELLS; HAPLOINSUFFICIENCY; HEMANGIOSARCOMA; HUMANS; INDOLES; MORPHOLINES; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHOPROTEIN PHOSPHATASES; PROTO-ONCOGENE PROTEINS C-AKT; PSEUDOPODIA; PYRROLES; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84883891473     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.012377     Document Type: Article

References (35)

1. Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L. et al. (2009). The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611-622.
2. Choorapoikayil, S., Kuiper, R. V., de Bruin, A. and den Hertog, J. (2012). Haploinsufficiency of the genes encoding the tumor suppressor Pten predisposes zebrafish to hemangiosarcoma. Dis. Model. Mech. 5, 241-247.
3. Croushore, J. A., Blasiole, B., Riddle, R. C., Thisse, C., Thisse, B., Canfield, V. A., Robertson, G. P., Cheng, K. C. and Levenson, R. (2005). Ptena and ptenb genes play distinct roles in zebrafish embryogenesis. Dev. Dyn. 234, 911-921.
4. Di Cristofano, A., Pesce, B., Cordon-Cardo, C. and Pandolfi, P. P. (1998). Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19, 348-355.
5. Faucherre, A., Taylor, G. S., Overvoorde, J., Dixon, J. E. and Hertog, J. (2008). Zebrafish pten genes have overlapping and non-redundant functions in tumorigenesis and embryonic development. Oncogene 27, 1079-1086.
6. Goberdhan, D. C., Paricio, N., Goodman, E. C., Mlodzik, M. and Wilson, C. (1999). Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev. 13, 3244-3258.
7. Graupera, M., Guillermet-Guibert, J., Foukas, L. C., Phng, L. K., Cain, R. J., Salpekar, A., Pearce, W., Meek, S., Millan, J., Cutillas, P. R. et al. (2008). Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration. Nature 453, 662-666.
8. Hagberg, C. E., Falkevall, A., Wang, X., Larsson, E., Huusko, J., Nilsson, I., van Meeteren, L. A., Samen, E., Lu, L., Vanwildemeersch, M. et al. (2010). Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 464, 917-921.
9. Hamada, K., Sasaki, T., Koni, P. A., Natsui, M., Kishimoto, H., Sasaki, J., Yajima, N., Horie, Y., Hasegawa, G., Naito, M. et al. (2005). The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev. 19, 2054-2065.
10. Herbert, S. P., Huisken, J., Kim, T. N., Feldman, M. E., Houseman, B. T., Wang, R. A., Shokat, K. M. and Stainier, D. Y. (2009). Arterial-venous segregation by selective cell sprouting: an alternative mode of blood vessel formation. Science 326, 294-298.
11. Huang, J. and Kontos, C. D. (2002). PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J. Biol. Chem. 277, 10760-10766.
12. Jin, S. W., Beis, D., Mitchell, T., Chen, J. N. and Stainier, D. Y. (2005). Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development 132, 5199-5209.
13. Jinnin, M., Medici, D., Park, L., Limaye, N., Liu, Y., Boscolo, E., Bischoff, J., Vikkula, M., Boye, E. and Olsen, B. R. (2008). Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat. Med. 14, 1236-1246.
14. Kikuchi, H., Miyazaki, S., Setoguchi, T., Hiramatsu, Y., Ohta, M., Kamiya, K., Sakaguchi, T. and Konno, H. (2012). Rapid relapse after resection of a sunitinibresistant gastrointestinal stromal tumor harboring a secondary mutation in exon 13 of the c-KIT gene. Anticancer Res. 32, 4105-4109.
15. Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. and Schilling, T. F. (1995). Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253-310.
16. Koch, S., Tugues, S., Li, X., Gualandi, L. and Claesson-Welsh, L. (2011). Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 437, 169-183.
17. Li, X., Tjwa, M., Van Hove, I., Enholm, B., Neven, E., Paavonen, K., Jeltsch, M., Juan, T. D., Sievers, R. E., Chorianopoulos, E. et al. (2008). Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium. Arterioscler. Thromb. Vasc. Biol. 28, 1614-1620.
18. Liang, D., Chang, J. R., Chin, A. J., Smith, A., Kelly, C., Weinberg, E. S. and Ge, R. (2001). The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development. Mech. Dev. 108, 29-43.
19. Liaw, D., Marsh, D. J., Li, J., Dahia, P. L., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacocke, M. et al. (1997). Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16, 64-67.
20. Ma, J., Sawai, H., Ochi, N., Matsuo, Y., Xu, D., Yasuda, A., Takahashi, H., Wakasugi, T. and Takeyama, H. (2009). PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Mol. Cell. Biochem. 331, 161-171.
21. Maehama, T. and Dixon, J. E. (1998). The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375-13378.
22. Marsh, D. J., Dahia, P. L., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R. J. and Eng, C. (1997). Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet. 16, 333-334.
23. Mihaylova, V. T., Borland, C. Z., Manjarrez, L., Stern, M. J. and Sun, H. (1999). The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway. Proc. Natl. Acad. Sci. USA 96, 7427-7432.
24. Montero, J. A., Kilian, B., Chan, J., Bayliss, P. E. and Heisenberg, C. P. (2003). Phosphoinositide 3-kinase is required for process outgrowth and cell polarization of gastrulating mesendodermal cells. Curr. Biol. 13, 1279-1289.
25. Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P. and Tonks, N. K. (1998). The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl. Acad. Sci. USA 95, 13513-13518.
26. Nasevicius, A., Larson, J. and Ekker, S. C. (2000). Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast 17, 294-301.
27. Roskoski, R., Jr (2007). Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. Biochem. Biophys. Res. Commun. 356, 323-328.
28. Stokoe, D. (2001). Pten. Curr. Biol. 11, R502.
29. Thisse, C. and Thisse, B. (2008). High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat. Protoc. 3, 59-69.
30. Tielen, R., Verhoef, C., van Coevorden, F., Gelderblom, H., Sleijfer, S., Hartgrink, H. H., Bonenkamp, J. J., van der Graaf, W. T. and de Wilt, J. H. (2012). Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile? World J. Surg. Oncol. 10, 111.
31. Tonini, G., Intagliata, S., Cagli, B., Segreto, F., Perrone, G., Onetti Muda, A., Santini, D. and Persichetti, P. (2010). Recurrent scrotal hemangiomas during treatment with sunitinib. J. Clin. Oncol. 28, e737-e738.
32. Weijts, B. G., Bakker, W. J., Cornelissen, P. W., Liang, K. H., Schaftenaar, F. H., Westendorp, B., de Wolf, C. A., Paciejewska, M., Scheele, C. L., Kent, L. et al. (2012). E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1. EMBO J. 31, 3871-3884.
33. Westerfield, M. (2000). The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio Rerio). Eugene, OR: Institute of Neuroscience, University of Oregon.
34. Zhiyong, C., Wentong, L., Xiaoyang, Y. and Ling, P. (2012). PTEN's regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia. Med. Oncol. 29, 1084-1092.
35. Zhou, X. P., Marsh, D. J., Morrison, C. D., Chaudhury, A. R., Maxwell, M., Reifenberger, G. and Eng, C. (2003). Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults. Am. J. Hum. Genet. 73, 1191-1198.